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Abstract
Airway epithelium structure/function can be altered by local
inflammatory/immune signals, and this process is called epithelial
remodeling. The mechanism by which this innate response is
regulated, which causes mucin/mucus overproduction, is largely
unknown. Exosomes are nanovesicles that can be secreted and
internalized by cells to transport cellular cargo, such as proteins,
lipids, and miRNA. The objective of this study was to understand
the role exosomes play in airway remodeling through cell–cell
communication. We used two different human airway cell cultures:
primary human tracheobronchial (HTBE) cells, and a cultured
airway epithelial cell line (Calu-3). After intercellular exosomal
transfer, comprehensive proteomic and genomic characterization
of cell secretions and exosomes was performed. Quantitative
proteomics and exosomal miRNA analysis profiles indicated that the
two cell types are fundamentally distinct. HTBE cell secretions were
typically dominated by fundamental innate/protective proteins,
includingmucinMUC5B, andCalu-3 cell secretions were dominated
by pathology-associated proteins, including mucin MUC5AC. After
exosomal transfer/intake, approximately 20% of proteins, including
MUC5AC and MUC5B, were significantly altered in HTBE
secretions. After exosome transfer, approximately 90 miRNAs (z4%)
were upregulated in HTBE exosomes, whereas Calu-3 exosomes
exhibited a preserved miRNA profile. Together, our data suggest that
the transfer of exosomal cargo between airway epithelial cells
significantly alters the qualitative and quantitative profiles of airway
secretions, including mucin hypersecretion, and the miRNA cargo of
exosomes in target cells. This finding indicates that cellular information
can be carried between airway epithelial cells via exosomes, which may
play an important role in airway biology and epithelial remodeling.
Keywords: exosomes; airway remodeling; mucin hypersecretion;
asthma; chronic obstructive pulmonary disease
The human airway mucosa is lined by
diverse epithelial cells, including ciliated and
secretory goblet cells on the surface and
serous and mucous cells in the submucosal
glands (1). This organization of cells
and secreted products contributes to
mucociliary clearance and mediates an
effective innate immune response to
environmental exposure that helps maintain
pulmonary homeostasis in both health
and disease states (2). Respiratory epithelial
cells modulate innate immune responses
by releasing protective molecules, such
as mucins, proteins (3), chemokines,
cytokines, and growth factors, that regulate
the migration and activation of diverse
immune cells to sites of insult and injury
(1, 4). Traditionally, cells were thought to
interact through small, secreted molecules,
such as hormones or growth factors, or
through membrane junctions (5). However,
the mechanism through which airway
cells maintain this complex environment/
interaction is poorly understood.
Exosomes, microvesicles, and apoptotic
bodies are all secreted membrane-bound
extracellular vesicles by definition, but their
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size, cellular origin, synthesis, cargo and
function are distinct. Exosomes have been
shown to be 40- to 120-nm, cup-shaped,
endosomal, membranous vesicles that are
secreted by nearly all cells, and to be present
(6) in many biological fluids, including
plasma, urine, saliva (7), BAL fluid (8),
semen, cerebral spinal fluid (9), breast
milk (10), and airway secretions (11). The
function of extracellular vesicles, exosomes in
particular, as novel mediators of intercellular
communication has become a recent focus of
extensive scientific research (12, 13).
Exosomes appear to be capable of
interacting with and being internalized by
nearly all cell types to transport cellular
cargo, such as proteins, lipids, and nucleic
acids (miRNA and mRNA) (13). Depending
on their origin, exosomes contain specific sets
of known proteins, including tetraspanins,
heat shock proteins (Hsps), annexins and
membrane-bound mucins; however, the role
of the individual components of exosomes is
still unknown. The functional role of exosomes
is well studied in various diseases, such as
cancer (14), diabetes (15), renal disorders (16),
and inflammation (17). However, the role
of exosomes in intercellular communication
in the airway epithelium and their
contributions to the innate defense against
and/or pathogenesis of lung diseases are
largely unknown.
We previously reported that cultured
primary airway epithelial cells (human
tracheobronchial [HTBE] cells) release
exosome-like vesicles with innate immune
properties (11). Here, we hypothesize that
airway epithelium–derived exosomes play a
major role in cell-to-cell communication
in the lung, and that these exosomes are
involved in regulating airway homeostasis
and remodeling by transferring cellular cargo
(miRNA or proteins). To test this hypothesis,
we used two phenotypically distinct airway
epithelial cell types: primary HTBE cells and
a cultured human airway epithelial cell line
(Calu-3). After controlled in vitro intercellular
exosomal transfer, comprehensive proteomic
and genomic characterization of cell secretions
and exosomes was performed to understand
alterations in the cell microenvironment
mediated by cellular cross-talk through
exosomes.
Methods
Additional details are provided in the data
supplemental materials.
Cell Culture
Two different airway cell culture systems
that secrete mucus were used in this study:
primary HTBE cells and the Calu-3 cell line.
HTBE cells were isolated and cultured as
previously described (11, 18). Calu-3 cells,
derived from human lung adenocarcinoma,
were maintained at the air–liquid interface
for at least 3 weeks, as previously described
(19). Apical secretions were obtained by
performing two sequential 1-ml PBS
washes on the surface of the cultures.
Culture washings obtained from HTBE
cells from five individuals (each with a
unique code identifier) were used.
Isolation and Characterization of
Exosomes
Exosomes were isolated from HTBE
and Calu-3 secretions using differential
centrifugation (11). Nanoparticle tracking
analysis was used for size and concentration
analysis of the isolated exosomes using
a NanoSight NS300 system (Malvern
Instruments), as described previously
(6). Each experiment was performed in
triplicate. Electron microscopy (EM)
analysis of exosomes was essentially
performed as previously described (6).
Exosome Transfer between Cells
Cells were washed three times with PBS, and
13 108 exosomes in 100 ml of PBS were
added to each well (n = 5) for 3 days; 100 ml
of PBS was added to the control wells (n =
5). The cells were thoroughly washed
with PBS on the fourth day, and the apical
cell washings were collected after 30
minutes of incubation with 1 ml of PBS.
Cell washings were collected for 3 days.
The washings from each well from all
collection times were pooled and aliquoted
for analysis.
Exosome Labeling and Uptake
To observe the exosomal uptake by the
recipient cells, Calu-3 exosomes were
labeled with SYTO RNASelect green
fluorescent stain and BODIPY TR ceramide
red fluorescent stain. The exosomes were
incubated at 378C for 15 minutes and then
purified from the excess dye using a
Sepharose CL-2B 10/30 gel filtration
column. As a control, PBS was mixed with
dyes and purified similarly. HTBE cells
were washed with PBS and treated with
13 108 labeled Calu-3 exosomes or the
same volume of SYTO RNASelect-BODIPY
TR-PBS control for 1.5 hours. Cells were
washed twice with PBS, fixed with 100%
ice-cold methanol, permeabilized with 0.1%
Triton X-100, and blocked with 3% BSA.
Cells were incubated with primary mouse
anti–b-tubulin IV antibody (BioGenex)
overnight at 48C and then stained with
secondary donkey anti-mouse Alexa 647
antibody and Hoechst. The z-stack confocal
images were acquired using an Olympus
FluoView FV1000 microscope with a 603
objective. Volocity software was used to
construct three-dimensional images and XZ
projections.
Mass Spectrometry
The samples were reduced, alkylated, and
trypsinized, and label-free quantitative mass
spectrometry (MS) was performed as
described previously (20). The raw file
was analyzed with Proteome Discoverer
1.3 software using the UniProt-human
complete FASTA databank, and trypsin was
set as the enzyme, with two max missed
cleavage sites; methionine oxidation
(115.995 Da) was set as the dynamic
modification, and carbamidomethylation
(157.021 Da) was set as the static modification.
Exosomal miRNA Library
AmiRNA library was constructed according
to the HTG EdgeSeq miRNA WTA ILM kit
instructions. Briefly, 15 ml of lysis buffer
was added to the 15-ml exosome sample.
Tubes were then heated to 958C for 15
minutes. Next, 1.5 ml of proteinase K was
added, and the sample was mixed well by
pipetting and incubated for 30 minutes at
508C in an orbital shaker. A total of 25 ml
of working lysate was transferred to each
well of the HTG EdgeSeq scanning plate.
Appropriate kit components for preparing
miRNA libraries were loaded into the
system platform, and the HTG EdgeSeq
program was started. The sequencing
adaptors and barcodes were added to the
sequencing libraries upon completion of
the HTG EdgeSeq run, and samples were
amplified using the PCR method. After
the PCR step, sequencing libraries were
concentrated, pooled, and then sequenced
on an MiSeq or HiSeq2500 RR Illumina




The miRNA raw count data were used as
input for differential expression analysis
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with the Bioconductor R package, edgeR
(21), which models the count data based
on the negative binomial distribution.
Differential expression between comparison
groups was analyzed with the sample
subsets using exact tests (22), and
multiple tests were corrected using the
Benjamini-Hochberg false discovery rate.
Statistical analyses comparing two groups
of proteomic data sets were performed
using a t test.
Results
Our experimental strategy is summarized
in Figure E1 in the data supplement.
Briefly, HTBE primary cell cultures and
the Calu-3 cell line were grown on an
air–liquid interface. Label-free quantitative
proteomics analysis of the secretions from
both cultures was performed before and
after exosomal exchange experiments.
Exosomes secreted from both HTBE
(HTBE-exo) and Calu-3 (Calu-3-exo) cells
were isolated and characterized, and their
protein and miRNA cargoes were studied.
Isolation and Initial Characterization
of Exosomes/Vesicles
Nanoparticle tracking analysis indicated
that the average size of HTBE-exo was 325
nm, and the average size of Calu-3-exo was
135 nm (Figures E2A and E2B). Electron
microscopy images of negatively stained
exosomal preparations showed typical, cup-
shaped nanovesicular structures with a
diameter in the range of 40–100 nm in both
exosome populations. A proportion of
HTBE-exo had membrane-tethered mucins
that increased their overall radius of
hydration in light scattering measurements
(Figure E2C). HTBE cell secretions contained
significantly more exosomes than Calu-3 cell
secretions (Figure E2D).
Proteomics Analysis of HTBE-exo and
Calu-3-exo
Proteomics analysis of the exosome
preparations identified approximately 57
proteins in HTBE-exo and 63 proteins in
Calu-3-exo, with 49 common proteins
(Figure E3). MS analysis showed the
presence of exosome-specific markers, such
as CD59, annexins, Hsps (Hsp70 and
Hsp90), cytoskeletal proteins, and PLUNC,
in exosomes from both cell types. The
proteomic profiles of both exosome types
were largely similar (Table E1). HTBE-exo
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Figure 1. Proteomics analysis of human tracheobronchial (HTBE) and Calu-3 cell secretions. (A) Venn diagram showing the total number of secreted
proteins identified in the secretions of HTBE and Calu-3 cells. (B) Heat map of proteins displaying significantly (t test P< 0.05) altered levels in HTBE and
Calu-3 secretions. (C) Interaction network of altered proteins demonstrating biological processes.
ORIGINAL RESEARCH
Gupta, Radicioni, Abdelwahab, et al.: Exosome-mediated Communication in the Airways 211
 
stem cell antigen at higher levels than found
in Calu-3-exo. In addition, HTBE-exo was
highly enriched in membrane-tethered
mucins (MUC1, MUC4, and MUC16).
HTBE-exo contained unique proteins
related to transmembrane ion transport
and ion channel activity, such as sodium
and chloride amino acid transporter
protein, sodium-dependent phosphate
transport protein 2B, erythrocyte band 7
integral membrane protein, the regulatory
protein Na(1)/H(1) exchanger regulatory
cofactor (NHERF1), and certain immune-
related proteins, such as complement
C3, polymeric Ig receptor (PIGR), and
carcinoembryonic antigen–related cell
adhesion molecule (CEACAM6) (Table
E2). Proteins present exclusively in
Calu-3-exo include MUC13, cell metabolic
proteins (g-glutamyltranspeptidase-1,
glyceraldehyde-3-phosphate dehydrogenase),
the cell surface peptidase, Neprilysin (CD10),
transmembrane glycoprotein prominin-1
(CD133 antigen), the molecular chaperone
endoplasmin, and immune-regulating
proteins (protein S100-A9, dipeptidyl
peptidase 4, and short PLUNC [SPLUNC1/
BPIFA1]) (Table E3).
Proteomics Analysis of Apical
Secretions from HTBE and Calu-3
Cells
In total, 245 and 336 proteins were identified
in secretions from HTBE cells and Calu-3
cells, respectively. Of these, 152 proteins
were unique to Calu-3 cells, and 61 were
unique to HTBE secretions. Proteomics
analysis of the secretions indicated that the
two-cell cultures had secretomes that were
approximately 50% distinct (Figure 1A).
Figure 1B shows unique and differentially
expressed proteins in the HTBE and Calu-3
secretomes. Although proteins, such as
SPLUNC1, mucin 4, involucrin, protein S-
100-A2, uteroglobin, thrombospondin-1,
fibulin-1, pigment epithelium-derived
factor, and tumor-associated calcium signal
transducer-2, were uniquely expressed
in HTBE cells, other proteins, such as
trefoil factor-2, olfactomedin-4, MUC13,
transcobalamin-1, MUC3B, voltage-
dependent anion-selective channel protein-1,
CEACAM7, aminopeptidase N, protein
AMBP, kallikrein-6, complement decay–
accelerating factor (CD55), nucleobindin-1,
and galectin-4, were present only in Calu-3
cells.
Label-free quantitative MS analysis
indicated that 30 proteins were differentially
expressed in both secretions (Figures 1B and
1C) at the baseline. The expression of the
main gel-forming mucins of the airways,
MUC5AC and MUC5B, was significantly
higher in Calu-3 secretions than in
HTBE secretions (Figures 2A and 2B).
The MUC5AC:MUC5B ratio was also
approximately 15-fold higher in Calu-3
secretions than in HTBE secretions
(Figure 2C). In addition, innate immune
response proteins, such as IgGFc-binding
protein (FCGBP), PIGR, and deleted in
malignant brain tumors (DMBT) 1, along with
the antiprotease alpha-1 antichymotrypsin
(SERPINA3), were significantly higher in
Calu-3 secretions (Figures 3A–3D). In
contrast, complement C3 and SPLUNC1
expression levels were higher in HTBE
























































































































Figure 2. Label-free quantitation of major gel-forming mucins in HTBE and Calu-3 cell secretions at baseline and after controlled exosome transfer.
(A) MUC5AC and (B) MUC5B expression levels were significantly higher in Calu-3 cells than in HTBE cells. After the exosome transfer experiment, the
expression levels of (D) MUC5AC and (E) MUC5B were significantly increased in HTBE secretions. (C) The ratio of MUC5AC and MUC5B were approximately
15-times higher in Calu-3 cell secretions compared to HTBE secretions. (F) The ratio in the Calu-3 cells further increased after the cells were treated with
HTBE-exo. Solid circles and solid squares denote Calu-3 and HTBE control secretions, respectively. Open circles and solid triangles denote control and
treated cultures, respectively. Statistical significance was determined by t tests; *P< 0.05, **P< 0.01, and ***P< 0.005. NS = not significant.
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Exosome Uptake by Recipient Cells
To investigate whether the exosomes were
taken up by recipient cells, we labeled both
exosomal RNA andmembranes using SYTO
RNASelect stain (green) and BODIPY TR
ceramide stain (red), respectively. Confocal
microscopy showed uptake of Calu-3
exosomes by HTBE cells, shown by strong
green and red fluorescent signals in the
whole-mount staining compared with
the dye control (Figure 4). The RNA
and membrane staining were generally
colocalized in the cells. Cilia (tubulin)
and nuclei (Hoechst) staining was used
as a cell marker to determine whether
exosomes were inside the cell or on the
surface.
Figure 4 indicates that the staining is
mostly localized in the nonciliated areas,
but there was also apparent staining in the
ciliated cells.
The Secretomes of Both Cultures
Change after Exosomal Exchange:
Exosome-mediated Information
Exchange and Altered Phenotype
To elucidate the mechanism of intercellular
communication between different airway
cell types, we transferred HTBE-exo and
Calu-3-exo to Calu-3 and HTBE cells,
respectively. Treatment with the exosomes
resulted in differential expression/regulation
of certain proteins in the target cells. Label-
free quantitative MS analysis of secretions
after treatment of the HTBE cells with Calu-
3-exo indicated that 95 new and unique
proteins were secreted by the HTBE cells,
and 66 of 311 proteins were significantly
increased in HTBE secretions. A similar
trend was observed in Calu-3 cells after
treatment with HTBE-exo; specifically, 65
new and unique proteins were detected in
the treated cells (Figures 5A and 5B).
The proteins that were significantly























































































































Figure 3. Relative abundance of certain innate defense proteins at baseline and after exosomal exchange. (A) FCGBP, (B) poly IgG receptor, (C) DMBT1,
(D) alpha-1 antitrypsin, (E) ceruloplasmin, (F) complement C3, (G) SPLUNC1, and (H) AGR2. The mean and SEM values are indicated by major and minor
horizontal bars, respectively. Open circles and solid triangles denote control and treated cultures, respectively. Statistical significance was determined by
one-way ANOVA; *P< 0.05, **P< 0.01, and ***P< 0.005.
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treatment were PIGR, WAP four-disulfide
core domain protein 2, retinoic acid receptor
responder protein 1, ceruloplasmin,
DMBT1, complement C3, the mucins,
MUC5B and MUC5AC, galectin-3–binding
protein, vitelline membrane outer layer
protein 1, histone H2B type 3-B, and
tetraspanin-1 (Figures 2D, 2E, 3, and 5C).
SERPINA3, insulin-like growth
factor–binding protein 3 (IGFBP3),
CEACAM6, 14-3-3 proteins, BPI
fold–containing family A member 1
(BPIFA1, SPLUNC1), anterior gradient
protein-2 (AGR2), vinculin, migration
and invasion enhancer 1, and selenium-
binding protein 1 were increased in Calu-3
cell secretions after exosome exchange,
whereas lactotransferrin, CD55, and
peroxiredoxin-2 were decreased (Figures 3
and 5D).
miRNA Analysis of HTBE-exo and
Calu-3-exo
A comprehensive miRNA comparison of
the two types of exosome-like vesicles
was performed to obtain an overview of
differences in miRNA expression patterns
that may have roles in intercellular
communication between different airway
epithelial cells and in disease pathogenesis.
These experiments were performed using
HTG EdgeSeq technology, and differential
expression was evaluated using EdgeR
software analysis.
Similarities and significant differences
were observed in miRNA expression
between Calu-3-exo and HTBE-exo
(Figure 6). More than 2,000 miRNAs were
detected in each exosome population. miR-
3960, miR-1246, miR-4497, miR-21, and
miR-4466 were among the most abundant
miRNAs in both exosomes (Figure 7A).
miR-6126, miR-663a, miR-149, miR-4281,
and miR-4792 were abundant in Calu-3-
exo, but not in HTBE-exo (Figure 7B).
Approximately 240 miRNAs were
differentially expressed in HTBE and
Calu-3 exosomes at baseline. Further
analysis indicated that miRNAs related to
inflammation and mucin production, such
as miR-18a-5p, miR-19a-3p, miR-141-3p,
miR-200a-3p, miR-200c-3p, miR-29a-3p,
and miR-29b-1-5p, which are involved
in cancer (23, 24) and respiratory
disease–related pathways, were more
abundantly expressed in Calu-3 cells. The
miRNA families, miR-34a, -b, and -c and
miR-449b and -c, which are known to
be involved in ciliogenesis (25), were
significantly more abundant in HTBE-exo
than in Calu-3-exo (Figure 7C). The list of
the top 50 miRNAs that were differentially
expressed in HTBE versus Calu-3 control
exosomes is shown in Table 1. Pathway
analysis using Diana miRPath showed that
these miRNAs were involved in a number
of pathways, including pathways related to
cancer and respiratory disease (Figure E4).
After exosomal transfer, few significant
differences were found between Calu-3–
treated exosomes; however, interestingly,
approximately 90 miRNAs were upregulated
in HTBE-exo compared with Calu-3-exo
(Figures 6C and 6D) after exosomal
transfer. Bioinformatic analysis of the
miRNA library showed that the expression
levels of miR-31-5p, miR-27b-3b,
miR-21-5p, miR-21-3p, miR-100-5p,
miR-34, and miR-449 were increased,
and the expression levels of miR-375,
miR-215-5p, and miR-192-5p were
decreased significantly in HTBE-exo after
the transfer. miR-3180 and miR-3180–3p
increased in Calu-3 treated- exosomes.
miR-18a-5p, 19a-3p, miR-141-3p,
miR-200a-3p, miR-200c-3p, miR29a-3p,
and miR-29b-1-5p were overexpressed
in Calu-3-exo and were found to be
upregulated in HTBE-exo after treatment
with Calu-3-exo.
Discussion
Airway epithelial cells form an essential
barrier for effective innate protection of
the lung. In response to chronic infection
and inflammation, the epithelial layer is
remodeled. Airway cells may contribute to
the pathogenesis of major chronic lung
disorders, including chronic obstructive
pulmonary disease, cystic fibrosis, asthma,
and bronchogenic carcinoma. In this
compromised state, the airway epithelium
becomes activated by various unknown
paracrine signaling molecules, leading to
various structural and functional changes
at the gene and protein level. Identification
of these signaling molecules is critical to
understanding the pathogenesis of these
diseases and to developing strategies to
treat diseases characterized by goblet cell
remodeling and mucus hypersecretion.
The focus of this study was to understand
the physiological relevance of exosomes
in intercellular communication and to
explore new mechanisms involved in lung
homeostasis, disease pathogenesis, and
airway remodeling.
The airway epithelial layer does not
function as an independent entity, but
rather as an interdependent functional unit
with differentiated epithelial cells (ciliated
and goblet cells), mesenchymal cells, and
endothelial cells, and with the extracellular
matrix, that form the bronchial walls.
How these cells coordinate to effect innate
10 m 10 m 10 m
Figure 4. Uptake of labeled exogenous Calu-3 exosomes by well-differentiated HTBE cells. Calu-3
exosomes (13 108) were labeled with SYTO RNASelect for RNA (green) and with BODIPY TR
ceramide for membranes (red) before incubation with HTBE cells. Labeled exosomes or an equal
volume of dye control were added to each well and incubated with cells for 1.5 hours at 378C; the
uptake of the labeled exosomes by HTBE cells was detected by confocal microcopy. Image of HTBE
cells after incubation with a dye control (left panel) and labeled exosomes (middle and right panels).
Top panels are extended focus XY projections, whereas the bottom panels are XZ projections. Ciliary
tubulin (anti–b-tubulin) is stained in white, and nuclei (DAPI) are shown in blue. Scale bars: 10 mm.
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protection is not known. Therefore, in
this study, to elucidate the mechanism
of intercellular communication between
different airway cells, we transferred HTBE-
exo and Calu-3-exo to Calu-3 and HTBE
cells, respectively. Multiple novel findings
were evident from these experiments. First,
we showed that exosomes can deliver
their cargo to recipient cells. Second, we
demonstrated that the two airway cell lines
are distinct and treatment with exosomes
derived from different cell types resulted in
differential expression/regulation of certain
proteins and miRNAs in the target cells,
especially the ones related to innate defense,
injury, and ciliogenesis. Last, we observed
that transferring the information carried by
exosomes/vesicles from one cell type to
another affects the secretory phenotype of
the recipient cells.
The MS-based proteome analysis
indicated that Calu-3 and HTBE cells
secreted qualitatively and quantitatively
distinct sets of proteins that were broadly
related to innate defense, stress/injury, and
regulatory pathways. Approximately 213
proteins were unique to both secretions,
which accounted for a distinct secretome
of approximately 50% (Figures 1A and
1B). The mucin, MUC4, is known to be
associated with cilia (26) and was unique
to HTBE culture secretions. However, the
mucins, MUC13 and MUC3B, were unique
to Calu-3 secretions, which may suggest
their role in cancer pathogenesis. The
proteins trefoil factor-2, kallikrein-6, CD55,
nucleobindin-1, and galectin-4 were present
only in Calu-3. Quantitative MS data
indicated that approximately 30 proteins
were differentially expressed in the
secretions, including the gel-forming
mucins, MUC5B and MUC5AC. MUC5AC
and MUC5B contribute to the viscoelastic
properties of mucus and are found at
elevated levels in the airways of individuals
with inflammation, chronic respiratory
diseases (27), and cancer (28). MUC5B is
essential for the formation of a flowing
mucus gel that is vital for epithelial
protection and mucociliary clearance






















































HTBE MUCUS CTRL HTBE MUCUS TX
29 216 95
B
CALU-3 MUCUS CTRL CALU-3 MUCUS TX
5 331 65
Figure 5. Label-free quantitation analysis of innate defense proteins in HTBE and Calu-3 cell secretions before and after exosomal exchange. (A and B)
Venn diagram showing the total number of proteins expressed in the mucus secretions of HTBE and Calu-3 cells before and after exosome transfer,
respectively. (C and D) Heat map showing the differentially expressed proteins in Calu-3 and HTBE cell secretions before and after treatment, respectively;
P, 0.05. CTRL = control; TX = treatment.
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significantly higher in Calu-3 secretions
compared with HTBE secretions. In the
lung, as well as in HTBE cultures, MUC5B
is the main gel-forming mucin. Increased
MUC5AC (which dominates Calu-3
secretions) and increased MUC5AC:MUC5B
ratio (15-fold higher in Calu3 secretions
compared with HTBE secretions) in the lung
generally associated with pathologies (27).
Other glycoproteins, such as AMBP, zinc-
alpha-2 glycoprotein, saposin D, and
leucine-rich alpha-2 glycoprotein, were
also significantly higher in Calu-3 cultures,
and these glycoproteins are found to be
upregulated in cancer cells (30). Furthermore,
innate response- and injury-related proteins,
such as PIGR, DMBT1, and FCGBP, were
significantly higher in Calu-3 secretions,
whereas complement C3, SPLUNC1, and
prostate stem cell antigens were higher in
HTBE secretions. Overall, the differential
expression of mucins and related innate
defense proteins suggests that HTBE
and Calu-3 cells secrete fundamentally
distinct secretions with unique protective/
pathogenic profiles.
After exchanging exosomes, both
HTBE and Calu-3 secretions were
significantly altered. Approximately 20% of
the proteins were significantly increased,
whereas 10% were significantly decreased.
In HTBE secretions, 95 unique proteins
were apparently elevated after exosome
transfer from Calu-3 cells. Importantly,
MUC5AC and MUC5B were significantly
elevated in HTBE secretions after the
transfer of Calu-3-exo. Given that mucin
hypersecretion is an aspect of airway
remodeling in chronic hypersecretory
conditions, including lung diseases induced
by cigarette smoking, we can surmise that
exosomes may play role in this pathological
process and contribute to the pathogenesis
of lung diseases characterized by airway
remodeling and mucin hypersecretion.
Similarly, Calu-3 cell secretions were
significantly altered after treatment with
HTBE-exo. Innate defense proteins and
proteins related to the inflammatory
response were increased in Calu-3 cells
after treatment with HTBE-exo, whereas
some stress/injury–related proteins were
decreased upon treatment. BPIFA1
(SPLUNC1), an important innate defense
protein in the airways (31, 32), was not
detected in Calu-3 cells at baseline, but was
markedly and significantly increased after
HTBE exosome transfer, providing further
insight into exosome-mediated changes in
protein expression. Although the dominant
Calu-3 mucin, MUC5AC, is slightly, but
not significantly, increased after the
exosome treatment, AGR2, a protein
associated with MUC5AC (over) production
(33), was significantly increased after the
transfer. The observed changes in the
proteome profiles and mucin secretions after
exosomal transfer suggests that exosomal
cargo may directly impact the protein
expression of recipient cells. Therefore, the
qualitative and quantitative alterations in
all these proteins mediated by exosomes
may be associated with airway epithelial
remodeling. Because these alterations are
correlated with the miRNA profile, the
response after the transfer could be a
result of reprogramming of the target cells
rather than physical stimulus. However, the
latter cannot be ruled out by the current
data, and needs to be investigated further.
In other words, the surface proteins on
exosomes may interact with recipient cells,
thereby potentially stimulating a certain
cell response.
miRNAs play fundamental roles in
several pulmonary diseases, including
interstitial lung disease, chronic obstructive
pulmonary disease, and asthma (34).
Exosomal miRNAs delivered to target
cells can significantly affect biological
pathways within target/recipient cells,
resulting in altered cellular function and





















































Calu-3, Control vs. Treated
Figure 6. Exosomal miRNA analysis. (A) Venn diagram showing changes in the number of miRNAs in
the exosomes of HTBE and Calu-3 cells before and after exosome transfer. (B) Log ratio and mean
average of the values (MA) plot showing differential miRNA expression in Calu-3-exo and HTBE-exo
controls, (C) differential miRNA expression in HTBE-exo after exosome exchange, and (D) differential
miRNA expression in Calu-3-exo after exosome exchange. Horizontal lines denote fold change of 2,
while red/blue highlighted dots represent significantly increased/decreased miRNAs at false discovery
rate ,0.01. Approximately 240 miRNAs were differentially expressed in HTBE and Calu-3-exo. After
exosome transfer, approximately 93 miRNAs were upregulated in HTBE-exo. CPM = counts per
million; FC = fold change.
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miRNAs are small, noncoding, endogenous,
single-stranded, conserved sequences that
mainly function by directly downregulating
(34) or indirectly upregulating gene
expression at the post-transcriptional level
through binding to mRNAs and preventing
their translation into proteins. A single
miRNA can regulate several genes, and
multiple miRNAs can regulate the same
gene with additive or synergistic effects. To
understand the role of miRNAs in the
unique secretory phenotype of these two
distinct cell types and to understand the
role of secretome changes after exosomal
exchange, we used exosomal miRNA
profiling. Two observations were evident
from the miRNA profiles: 1) the two cell
types released distinct sets of miRNAs
through their exosomes; and 2) after
exosomal exchange, approximately 5% of
the miRNA profile was altered in the HTBE
cultures compared with the less than a 1%
alteration observed in Calu-3 cells. We
previously showed that airway epithelial
exosomes carry small RNAs (11). Here,
we demonstrated that these exosomes
also carry miRNAs. Microarray analysis
followed by next-generation sequencing
detected more than 2,000 miRNAs in these
cultures. Similar to their proteome content,
these two distinct cell cultures exhibited
distinct miRNA profiles. When we
compared the differentially expressed
miRNAs and proteins between Calu-3 and
HTBE cells through pathway analyses, we
observed that miRNAs, which are upstream
regulators of protein expression, affected
the cell state and function. Proteins present























































































































































































































































































































































































Figure 7. Expression levels of the abundant miRNAs in HTBE and Calu-3 exosomes. (A) The expression levels of the most abundant miRNAs unique to
each group. (B) A total of 16 of the top 50 most abundant miRNAs were common in both HTBE and Calu-3 exosomes, though most of these were orders
of magnitude higher in Calu-3 exosomes. (C) The expression levels of the miR-34/449 group (associated with ciliogenesis) and miR223 (associated with
acute lung injury) were upregulated in HTBE exosomes. Statistical significance was determined by t tests; *P< 0.05, ***P< 0.005.
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IGFBP3 and SLP1, were found to be
regulated by a number of miRNAs,
including miRNA-4497, miR-4792, miR-
6752-5p, miR-143-3p, miR-125b-5p (35),
miR-34a-5p (25), and miR-664-3p, using
ingenuity pathway analysis software. mir-
196a, mir-101-3p, miR-31-5p, and certain
miRNAs from the 17–92 cluster (24) were
observed at higher levels in Calu-3-exo.
These miRNAs are known to be overexpressed
in human lung cancer and to promote cell
proliferation. miR-3180 has been found to be
involved in the proliferation of smooth
muscle cells in the bladder through the
Cdk2 signaling pathway (36). miR-19a and
miR-19b-3p (37), along with miR-141 and
miR-200c, are known to be involved in
cancer metastasis and to play a role in
epithelial–mesenchymal transition. miR-21,
miR-146a, miR-146b, and miR-32-5p have
been observed to be higher in patients with
acute lung injury. Therefore, the miRNAs
that were upregulated in HTBE-exo suggest
that HTBE cells sustain some form of injury
after treatment with exosomes from the
cancerous Calu-3 cell line. In addition,
we investigated the molecular network
that can be activated by miRNAs that are
differentially expressed in HTBE and Calu-
3-exo. MYC and the NF-kb complex
seemed to be central regulators in the
molecular network.
It is apparent from the quantitative
proteomic analysis that Calu-3 cells
secrete significantly more gel-forming
mucins, MUC5B (z4-fold) and MUC5AC
(z90-fold). This could be due to the
genotype/phenotype of Calu-3 cells, which
may tend to promote secretion of more
mucins/mucus, and because Calu-3 cells
exhibit a secretory goblet cell–rich
phenotype compared with HTBE cells,
60–80% of which are ciliated. After the
exosomal exchange, MUC5AC and
MUC5B levels increased in the HTBE
secretions. Therefore, it is critical to know
the relationship between these mucins and
exosomes. To further understand this
finding, we attempted to correlate this
tendency with the miRNA profiles of the
two cell lines. Unfortunately, limited
information is available on the relationship
between miRNA and mucin secretion.
Using structural and functional pathway
analyses, miR-149-3p was predicted to
regulate the expression of MUC5B (Figure
E5), and no correlation was found for the
regulation of MUC5AC. Although limited
information is available in the literature
associating miRNAs with mucin expression
and secretion, these differentially expressed
miRNAs in Calu-3 cells may represent a
future target for screening studies. In
addition, an interaction between the
abundant gel-forming mucins and the
exosomes is possible. The presence of
MUC5AC and MUC5B in the exosomal
preparation (Tables E1–E3) suggests a
copurification, likely via an interaction
between them. Validation of such
interactions and consequences requires
further studies. Ciliated cells are terminal
cells that are affected by insult and injury as
a part of airway remodeling in addition
to goblet cell hyperplasia. Recently, miR-
34/449 was shown to be important in
ciliogenesis by altering the expression of a
centriolar protein known to suppress cilia
assembly (38, 39). In addition, vesicular
Table 1. List of top 50 miRs differentially expressed in Calu-3 versus HTBE exosomes
Probe logFC P Value FDR
miR-192-5p 7.983572 7.02E244 1.58E240
miR-194-5p 8.065975 1.83E243 2.06E240
miR-205-5p 28.65767 1.13E232 8.50E230
miR-375 5.741463 2.83E230 1.60E227
miR-215-5p 5.463103 5.80E230 2.62E227
miR-6727-5p 5.157095 8.50E229 3.20E226
miR-6780b-5p 5.43189 6.90E224 2.22E221
miR-6126 5.028427 1.09E220 3.07E218
miR-130b-3p 3.93613 5.64E218 1.41E215
miR-663a 4.146252 1.31E217 2.97E215
miR-6752-5p 5.546187 5.11E216 1.05E213
miR-10b-5p 3.140973 5.24E215 9.85E213
miR-15b-5p 3.282913 1.73E213 3.01E211
miR-6799-5p 4.257163 2.45E213 3.95E211
miR-192-3p 2.847477 3.00E213 4.51E211
miR-92a-3p 2.968258 9.69E213 1.37E210
miR-654-5p 4.461773 1.22E212 1.62E210
miR-101-3p 2.92049 1.61E212 2.02E210
miR-4634 3.120529 2.82E212 3.35E210
miR-149-3p 3.657877 8.64E212 9.74E210
miR-10a-5p 4.732037 1.77E211 1.91E209
miR-30b-5p 2.815723 2.29E211 2.35E209
miR-320c 2.932861 2.85E211 2.80E209
miR-320b 2.735203 3.09E211 2.91E209
miR-28-5p 2.661624 1.72E210 1.56E208
miR-1237-5p 2.899386 3.82E210 3.31E208
miR-20a-5p 2.6251 4.13E210 3.45E208
miR-564 2.852591 4.57E210 3.68E208
miR-424-5p 2.642337 5.55E210 4.32E208
miR-19a-3p 2.488099 1.06E209 7.94E208
miR-3197 2.773846 1.12E209 8.18E208
miR-186-5p 2.534553 1.49E209 1.05E207
miR-19b-3p 2.59162 1.81E209 1.24E207
miR-4463 2.833971 2.80E209 1.86E207
miR-138-5p 22.97975 3.21E209 2.07E207
miR-193b-3p 2.5112 3.37E209 2.11E207
miR-320e 2.421153 5.36E209 3.27E207
miR-4306 2.354884 6.13E209 3.64E207
let-7i-5p 2.684296 6.51E209 3.76E207
miR-638 2.963232 8.70E209 4.91E207
miR-362-3p 2.325304 9.16E209 5.04E207
miR-320d 2.545148 1.00E208 5.39E207
miR-17-5p 2.391188 1.09E208 5.72E207
miR-7-5p 2.337118 1.28E208 6.59E207
miR-148b-3p 2.28763 1.41E208 7.07E207
miR-20b-5p 2.273357 2.03E208 9.72E207
miR-29a-3p 2.437546 2.02E208 9.72E207
miR-148a-3p 2.253075 2.20E208 1.03E206
miR-4461 2.535988 2.68E208 1.23E206
miR-4281 3.299971 3.25E208 1.47E206
Definition of abbreviations: FC = fold change; FDR = false discovery rate; HTBE = human
tracheobronchial; miR =microRNA.
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miR-223 was recently shown to protect
against lung injuries in mice (40). These
miRNAs were significantly more abundant
in HTBE-exo, and interestingly, we observed
that the baseline level of miR-34/449 was
upregulated in HTBE-exo, suggesting
upregulated cilia biogenesis in these cells
after treatment. Downregulation of miR-29
is associated with pulmonary fibrosis (41).
miR-29 was detected in both Calu3 and
HTBE cells, and was increased in HTBE
cell–derived exosomes after exosomal
exchange.
Exosome-mediated information
transfer and cellular cross-talk have
previously been shown in other systems,
such as human and mouse mast cells
(13), tumor microenvironments, tumor
malignancies (42), and cancer metastasis
(43). To the best of our knowledge, this is
the first report of these phenomena in
airway epithelial cells. The lung is a unique
organ, considering the broad range of cells
that are found within the parenchyma and
airway structures. Cell–cell communication
is essential for optimal functioning of the
lung, and exosomes are therefore expected
to be important players in lung biology
and function (44). We previously showed
that exosomes in the airway can play a
role in innate defenses. Our present study
highlights a new role for the cargo of
airway epithelial–derived exosomes as
modulating/regulating factors in the airway
remodeling process. This study focused on
cultured epithelial cell exosomes. However,
other cells, such as macrophages and
neutrophils, are also important sources of
exosomes in the lung. Therefore, further
studies combining all these factors are
necessary to clarify the contribution of
airway exosomes derived from resident
epithelia and blood cells in lung homeostasis
and in the innate response to infection and
inflammation.
Exosome and miRNA research is
an emerging field, despite its technical
and biological challenges. Currently,
more than 2,000 miRNAs have been
characterized, but the identification of
their target genes and functions is still
in its infancy. Future studies focusing
on the role of exosomal cargo–, miRNA-,
and protein-mediated intercellular
communication between different
airway epithelial cells and between
macrophages/neutrophils and airway
epithelial cells are desperately needed to
better understand the coordinatedinnate
immune response of the lung. In
conclusion, our data suggest that transfer
of exosomal cargo between cells
significantly alters protein expression,
and reorganizes the miRNA cargo of
exosomes in target cells, indicating
that cellular information can be carried
between airway epithelial cells via
exosomes. Therefore, exosomes may play
an important role in airway biology and
epithelial remodeling. n
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